Literature DB >> 16434677

Detection of floccular hypometabolism in downbeat nystagmus by fMRI.

R Kalla1, A Deutschlander, K Hufner, T Stephan, K Jahn, S Glasauer, T Brandt, M Strupp.   

Abstract

The authors evaluated floccular activity with fMRI during the performance of vertical smooth pursuit eye movements in four patients with downbeat nystagmus (DBN) due to cerebellar degeneration and in 16 healthy controls. Region of interest analysis revealed a significantly diminished activation of both floccular lobes during downward but not upward pursuit in DBN. These imaging data support the view that a functional deficiency of the flocculi in downward pursuit causes DBN.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434677     DOI: 10.1212/01.wnl.0000194242.28018.d9

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

Review 1.  What we know about the generation of nystagmus and other ocular oscillations: are we closer to identifying therapeutic targets?

Authors:  Rebecca Jane McLean; Irene Gottlob; Frank Antony Proudlock
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

2.  Current treatment of vestibular, ocular motor disorders and nystagmus.

Authors:  Michael Strupp; Thomas Brandt
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

3.  Up-down asymmetry of cerebellar activation during vertical pursuit eye movements.

Authors:  Stefan Glasauer; Thomas Stephan; Roger Kalla; Sarah Marti; Dominik Straumann
Journal:  Cerebellum       Date:  2009-05-05       Impact factor: 3.847

4.  Downbeat nystagmus: evidence for enhancement of utriculo-ocular pathways by ocular vestibular evoked myogenic potentials?

Authors:  Tatiana Bremova; Stefan Glasauer; Michael Strupp
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-30       Impact factor: 2.503

5.  Transition from downbeat to upbeat nystagmus caused by 4-aminopyridine.

Authors:  K Feil; J Claaßen; S Bardins; J Teufel; M Habs; R Kalla; M Strupp
Journal:  J Neurol       Date:  2013-04-18       Impact factor: 4.849

Review 6.  Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.

Authors:  Katharina Feil; Tatiana Bremova; Carolin Muth; Roman Schniepp; Julian Teufel; Michael Strupp
Journal:  Cerebellum       Date:  2016-02       Impact factor: 3.847

7.  Dalfampridine in patients with downbeat nystagmus--an observational study.

Authors:  Jens Claassen; Katharina Feil; Stanislav Bardins; Julian Teufel; Rainer Spiegel; Roger Kalla; Erich Schneider; Klaus Jahn; Roman Schniepp; Michael Strupp
Journal:  J Neurol       Date:  2013-04-16       Impact factor: 4.849

8.  Diagnosis and treatment of vertigo and dizziness.

Authors:  Michael Strupp; Thomas Brandt
Journal:  Dtsch Arztebl Int       Date:  2008-03-07       Impact factor: 5.594

9.  Evidence for modulation of opioidergic activity in central vestibular processing: A [(18)F] diprenorphine PET study.

Authors:  Bernhard Baier; Sandra Bense; Frank Birklein; Hans-Georg Buchholz; Anja Mischke; Matthias Schreckenberger; Marianne Dieterich
Journal:  Hum Brain Mapp       Date:  2010-04       Impact factor: 5.038

10.  [Vertigo and dizziness: the neurologist's perspective].

Authors:  M Strupp
Journal:  Ophthalmologe       Date:  2013-01       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.